INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,886 | -60.8% | 263 | -51.8% | 0.00% | 0.0% |
| Q1 2024 | $15,020 | -18.6% | 546 | -9.8% | 0.00% | -50.0% |
| Q4 2023 | $18,446 | +159.3% | 605 | +168.9% | 0.00% | +100.0% |
| Q3 2023 | $7,115 | -1.4% | 225 | +27.1% | 0.00% | 0.0% |
| Q2 2023 | $7,218 | +127.8% | 177 | +108.2% | 0.00% | – |
| Q1 2023 | $3,168 | -21.7% | 85 | -26.7% | 0.00% | – |
| Q4 2022 | $4,047 | -68.9% | 116 | -51.5% | 0.00% | -100.0% |
| Q3 2022 | $13,000 | +18.2% | 239 | +9.6% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -35.3% | 218 | -5.2% | 0.00% | -33.3% |
| Q1 2022 | $17,000 | -76.1% | 230 | -61.7% | 0.00% | -72.7% |
| Q4 2021 | $71,000 | +1083.3% | 600 | +1150.0% | 0.01% | +450.0% |
| Q3 2021 | $6,000 | -25.0% | 48 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -33.3% | 48 | -66.9% | 0.00% | -33.3% |
| Q1 2021 | $12,000 | +200.0% | 145 | -22.5% | 0.00% | +200.0% |
| Q2 2020 | $4,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |